Association Between the Adiponectin +45T>G Genotype and Risk of Cardiovascular Disease: A Meta-analysis

Heart Lung and Circulation

Volumn 23, Issue 2, 2014, Pages 159-165

  Zhou, Donghui ^a   Jin, Yuanzhe ^a   Yao, Fengchen ^a   Duan, Zhiying ^a   Wang, Qi ^a   Liu, Jing ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

+45T>G; Adiponectin; Cardiovascular disease; Meta analysis; Polymorphism

Indexed keywords

+45T>G; ADIPONECTIN; CARDIOVASCULAR DISEASE; META-ANALYSIS; POLYMORPHISM;

ADIPONECTIN; CARDIOVASCULAR DISEASES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENOTYPE; HUMANS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; PUBMED; RISK FACTORS;

EID: 84894285110     PISSN: 14439506     EISSN: 14442892     Source Type: Journal    
DOI: 10.1016/j.hlc.2013.07.010     Document Type: Article

References (43)

1. Al-Daghri N.M., Al-Attas O.S., Alokail M.S., Alkharfy K.M., Hussain T. Adiponectin gene variants and the risk of coronary artery disease in patients with type 2 diabetes. Mol Biol Rep 2011, 38:3703-3708.
2. Bacci S., Menzaghi C., Ercolino T., Ma X.W., Rauseo A., Salvemini L., et al. The +276 G/T single nucleotide polymorphism of the adiponectin gene is associated with coronary artery disease in type 2 diabetic patients. Diabetes Care 2004, 27:2015-2020.
3. Berg A.H., Combs T.P., Scherer P.E. ACRP30/adiponectin: an adipokine regulating glucose and lipid metabolism. Trends Endocrinol Metab 2002, 13:84-89.
4. Boumaiza I., Omezzine A., Rejeb J., Rebhi L., Ben R., Nabilaa N., et al. Single-nucleotide polymorphisms at the adiponectin locus and risk of coronary artery disease in Tunisian coronaries. Journal of Cardiovascular Medicine 2011, 12:619-624.
5. Chandran M., Phillips S.A., Ciaraldi T., Henry R.R. Adiponectin: more than just another fat cell hormone?. Diabetes Care 2003, 26:2442-2450.
6. Chang Y.-C., Jiang J.-Y., Jiang Y.-D. Interaction of ADIPOQ genetic polymorphism with blood pressure and plasma cholesterol level on the risk of coronary artery disease. Circ J 2009, 73:1934-1938.
7. Chen X.L., Chen J.Q., Zhang R.L., Liu J.P., Li X.X., Tong Y.Q., et al. Study on the relationship between polymorphism of adiponectin gene and risk of ischemic stroke among Han population in the Northern parts of China. Chin J Epidemiol 2010, 31:129-132.
8. Chen F., Wu H.L., Yang Q.L., Liu Y.J., Wang J., Yang R.Y. Study on the correction of adiponectin gene polymorphism and coronary heart disease in the patients with metabolic syndrome in Han nationality population in Ningxia. Chin J Crit Care Med 2012, 32:24-29.
9. Chiodini B.D., Specchia C., Gori F., Barlera S., D'Orazio A., Pietri S., et al. Adiponectin gene polymorphisms and their effect on the risk of myocardial infarction and type 2 diabetes: an association study in an Italian population. Therapeut Adv Cardiovasc Disease 2010.
10. DerSimonian R., Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986, 7:177-188.
11. Egger M., Davey Smith G., Schneider M., Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997, 315:629-634.
12. Esteghamati A., Mansournia N., Nakhjavani M., Mansournia M.A., Nikzamir A., Abbasi M. Association of +45 (T/G) and +276 (G/T) polymorphisms in the adiponectin gene with coronary artery disease in a population of Iranian patients with type 2 diabetes. Mol Biol Rep 2012, 39:3791-3797.
13. Foucan L., Ezourhi N., Maimaitiming S., Hedreville S., Inamo J., Atallah A., et al. Adiponectin multimers and ADIPOQ T45G in coronary artery disease in Caribbean type 2 diabetic subjects of African descent. Obesity 2009, 18:1466-1468.
14. Gable D., Hurel S., Humphries S. Adiponectin and its gene variants as risk factors for insulin resistance, the metabolic syndrome and cardiovascular disease. Atherosclerosis 2006, 188:231.
15. Galbraith R. A note on graphical presentation of estimated odds ratios from several clinical trials. Stat Med 1988, 7:889-894.
16. Hegener H.H., Lee I.-M., Cook N.R., Ridker P.M., Zee R.Y.L. Association of adiponectin gene variations with risk of incident myocardial infarction and ischemic stroke: a nested case-control study. Clin Chem 2006, 52:2021-2027.
17. Heid I.M., Wagner S.A., Gohlke H., Iglseder B., Mueller J.C., Cip P., et al. Genetic architecture of the APM1 gene and its influence on adiponectin plasma levels and parameters of the metabolic syndrome in 1,727 healthy Caucasians. Diabetes 2006, 55:375-384.
18. Higgins J.P., Thompson S.G., Deeks J.J., Altman D.G. Measuring inconsistency in meta-analyses. BMJ 2003, 327:557-560.
19. Hirschhorn J.N., Lohmueller K., Byrne E. A comprehensive review of genetic association studies. Genet Med 2002, 4:45-61.
20. Hu H.H., Jiang X.W., Shen F., Shen J., Xu H. Adiponectin gene polymorphism in Han people of Jiaxing region and its association with coronary heart disease. J Jiaxing Univ 2011, 3:52-55.
21. Jung C.-H., Rhee E.-J., Kim S.-Y., Shin H.S., Kim B.J., Sung K.C., et al. Associations between two single nucleotide polymorphisms of adiponectin gene and coronary artery diseases. Endocr J 2006, 53:671.
22. Lacquemant C., Froguel P., Lobbens S., Izzo P., Dina C., Ruiz J. The adiponectin gene SNP +45 is associated with coronary artery disease in Type 2 (non-insulin-dependent) diabetes mellitus. Diabet Med 2004, 21:776-781.
23. Liu F., He Z., Deng S., Zhang H., Li N., Xu J.L. Association of adiponectin gene polymorphisms with the risk of ischemic stroke in a Chinese Han population. Mol Biol Rep 2011, 38:1983-1988.
24. Luo S.X., Han L., Liu Q., Ma K.H., Xiang L., Cao J.J. Study on the relationship between adiponectin +45 nucleotide T/G polymorphism and coronary heart disease. Chongqin Med 2010, 39:1517-1519.
25. Maeda K., Okubo K., Shimomura I., Funahashib T., Matsuzawab Y., Matsubaraa K. cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose Most abundant Gene transcript 1). Biochem Biophys Res Commun 1996, 221:286-289.
26. Mantel N., Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959, 22:719-748.
27. Mantel N., Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. Challenge Epidemiol: Issues Selected Readings 2004, 1:533-553.
28. Matsuda M., Shimomura I., Sata M., Arita Y., Nishida M., Maeda N., et al. Role of adiponectin in preventing vascular stenosis. the missing link of adipo-vascular axis. J Biol Chem 2002, 277:37487-37491.
29. Menzaghi C., Ercolino T., Di Paola R., Berg A.H., Warram J.H., Scherer P.E., et al. A haplotype at the adiponectin locus is associated with obesity and other features of the insulin resistance syndrome. Diabetes 2002, 51:2306-2312.
30. Namvaran F., Rahimi-Moghaddam P., Azarpira N., Nikeghbalian S. The association between adiponectin (+45T/G) and adiponectin receptor-2 (+795G/A) single nucleotide polymorphisms with cirrhosis in Iranian population. Mol Biol Rep 2012, 39:3219-3223.
31. Okamoto Y., Arita Y., Nishida M., Ouchi N., Takahashi M., Igura T., et al. An adipocyte-derived plasma protein, adiponectin, adheres to injured vascular walls. Horm Metab Res 2000, 32:47-50.
32. Qi L., Li T., Rimm E., Zhang C., Rifai N., Hunter D., et al. The +276 polymorphism of the APM1 gene, plasma adiponectin concentration, and cardiovascular risk in diabetic men. Diabetes 2005, 54:1607-1610.
33. Qi L., Doria A., Manson J.E., Meigs J.B., Hunter D., Mantzoros C.S., et al. Adiponectin genetic variability, plasma adiponectin, and cardiovascular risk in patients with type 2 diabetes. Diabetes 2006, 55:1512-1516.
34. Rizk N.M., El-Menyar A., Marei I., Sameer M., Musad T., Younis D., et al. Association of adiponectin gene polymorphism (+T45G) with acute coronary syndrome and circulating adiponectin levels. Angiology 2012.
35. Sabouri S., Ghayour Mobarhan M., Moohebati M., Hassani M., Kassaeian J., Tatari F., et al. Association between 45T/G polymorphism of adiponectin gene and coronary artery disease in an Iranian population. Sci World J 2011, 11:93-101.
36. Stenvinkel P., Marchlewska A., Pecoits-Filho R., Heimbürger O., Zhang Z.Z., Hoff C., et al. Adiponectin in renal disease: relationship to phenotype and genetic variation in the gene encoding adiponectin. Kidney Int 2004, 65:274-281.
37. Stuck A.E., Rubenstein L.Z.D., Wieland J.P., Vandenbroucke J.P., Irwig L., Macaskill P., et al. Bias in meta-analysis detected by a simple, graphical test. BMJ 1998, 316:469-471.
38. Tobias A. metainf, sbe26: assessing the influence of a single study in the meta-analytic estimate. Stata Techn Bull Reprints 1999, 8:108-110.
39. Wang J.N., Li S.M. Adiponectin gene polymor~~anin hart people ofmI.n region and its association th ofl'o~ heart disease. Chin J Diagn 2006, 10:1272-1274.
40. Wacholder S., Chanock S., Garcia-Closas M. Assessing the probability that a positive report is false: an approach for molecular epidemiology studies. J Natl Cancer Inst 2004, 96:434-442.
41. Xu L., Lin W.H. Correlation of adiponectin gene SNIP +45 T/G polymorphism with coronary heart disease. Chin J Pathophysiol 2010, 26:1064-1068.
42. Yamauchi T., Kamon J., Waki H., Imai Y., Shimozawa N., Hioki K., et al. Globular adiponectin protected ob/ob mice from diabetes and ApoE-deficient mice from atherosclerosis. J Biol Chem 2003, 278:2461-2468.
43. Zhang X.L., Peng W.H., Lu L., Wu L.Q., Gu G., Wang L.J., et al. Correlation of adiponectin gene polymorphisms with coronary artery disease and plaque Progresslon. J Shanghai Jiaotong Univ 2009, 29:435-439.